chr21-34887039-A-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1BP2

This summary comes from the ClinGen Evidence Repository: NM_001754.4(RUNX1):c.155T>A (p.Met52Lys) is a missense variant which has a MAF of 0.0007121 (0.071%, 840/1,179,678 alleles, including 1 homozygote) in the European (non-Finnish) subpopulation of the gnomAD v4.1.0 cohort, meeting the threshold for BS1 and BP2. In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014581/MONDO:0011071/008

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 1 hom. )

Consequence

RUNX1
NM_001754.5 missense

Scores

7
11

Clinical Significance

Likely benign reviewed by expert panel U:8B:2O:1

Conservation

PhyloP100: 6.86

Publications

13 publications found
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RUNX1 Gene-Disease associations (from GenCC):
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, G2P
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001754.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
NM_001754.5
MANE Select
c.155T>Ap.Met52Lys
missense
Exon 4 of 9NP_001745.2
RUNX1
NM_001001890.3
c.74T>Ap.Met25Lys
missense
Exon 1 of 6NP_001001890.1Q01196-1
RUNX1
NM_001122607.2
c.74T>Ap.Met25Lys
missense
Exon 1 of 5NP_001116079.1Q01196-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
ENST00000675419.1
MANE Select
c.155T>Ap.Met52Lys
missense
Exon 4 of 9ENSP00000501943.1Q01196-8
RUNX1
ENST00000300305.7
TSL:1
c.155T>Ap.Met52Lys
missense
Exon 3 of 8ENSP00000300305.3Q01196-8
RUNX1
ENST00000344691.8
TSL:1
c.74T>Ap.Met25Lys
missense
Exon 1 of 6ENSP00000340690.4Q01196-1

Frequencies

GnomAD3 genomes
AF:
0.000270
AC:
41
AN:
152132
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000258
AC:
60
AN:
232566
AF XY:
0.000249
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000586
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000523
Gnomad OTH exome
AF:
0.000343
GnomAD4 exome
AF:
0.000597
AC:
865
AN:
1449282
Hom.:
1
Cov.:
35
AF XY:
0.000560
AC XY:
404
AN XY:
721512
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33464
American (AMR)
AF:
0.0000224
AC:
1
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86216
European-Finnish (FIN)
AF:
0.0000483
AC:
2
AN:
41450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000721
AC:
801
AN:
1111670
Other (OTH)
AF:
0.000963
AC:
58
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000270
AC:
41
AN:
152132
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41414
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000573
AC:
39
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000729
Hom.:
0
Bravo
AF:
0.000344
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000710
AC:
6
ExAC
AF:
0.000201
AC:
24
EpiCase
AF:
0.000491
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
1
-
Anaplastic ependymoma (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome (1)
-
-
1
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
not specified (1)
-
1
-
RUNX1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.48
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.79
D
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.90
D
MetaRNN
Uncertain
0.72
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.4
M
PhyloP100
6.9
PrimateAI
Pathogenic
0.89
D
PROVEAN
Uncertain
-3.9
D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.97
D
Vest4
0.70
MVP
0.99
MPC
2.0
ClinPred
0.28
T
GERP RS
5.0
PromoterAI
0.053
Neutral
Varity_R
0.88
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200431130; hg19: chr21-36259336; COSMIC: COSV55868681; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.